Adm1n at 11:51, 15 February 2015

2015-02-15T11:51:21Z

Adm1n: Created page with "HU-308 is a drug that acts as a cannabinoid agonist. It is highly selective for the CB2 receptor subtype, with a selectivity of over 5000x for CB2 vs CB1. The synt..."

2015-02-15T11:51:08Z

Created page with "HU-308 is a drug that acts as a cannabinoid agonist. It is highly selective for the CB2 receptor subtype, with a selectivity of over 5000x for CB2 vs CB1. The synt..."

New page

HU-308 is a drug that acts as a [[cannabinoid]] agonist. It is highly selective for the [[CB2 receptor]] subtype, with a selectivity of over 5000x for CB2 vs [[CB1]]. The synthesis and characterization took place in the laboratory of Prof. Mechoulam at the Hebrew University of Jerusalem in the late 1990s. It has analgesic effects, promotes proliferation of neural stem cells, and protects both liver and blood vessel tissues against oxidative stress via inhibition of TNF-α.

== Legal status ==

'''United States'''

HU-308 is not scheduled at the federal level in the United States.

'''Florida'''

"HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol)" is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in Florida.

==See also==

* [[HU-210]]

* [[HU-320]]

← Older revision		Revision as of 11:51, 15 February 2015
Line 1:		Line 1:
−	HU-308 is a drug that acts as a [[cannabinoid]] agonist. It is highly selective for the [[CB2 receptor]] subtype, with a selectivity of over 5000x for CB2 vs [[CB1]]. The synthesis and characterization took place in the laboratory of Prof. Mechoulam at the Hebrew University of Jerusalem in the late 1990s. It has analgesic effects, promotes proliferation of neural stem cells, and protects both liver and blood vessel tissues against oxidative stress via inhibition of TNF-α.	+	'''HU-308''' is a drug that acts as a [[cannabinoid]] agonist. It is highly selective for the [[CB2 receptor]] subtype, with a selectivity of over 5000x for CB2 vs [[CB1]]. The synthesis and characterization took place in the laboratory of Prof. Mechoulam at the Hebrew University of Jerusalem in the late 1990s. It has analgesic effects, promotes proliferation of neural stem cells, and protects both liver and blood vessel tissues against oxidative stress via inhibition of TNF-α.

HU-308 - Revision history

Adm1n at 11:51, 15 February 2015

Adm1n: Created page with "HU-308 is a drug that acts as a cannabinoid agonist. It is highly selective for the CB2 receptor subtype, with a selectivity of over 5000x for CB2 vs CB1. The synt..."